Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Title:Meet Our Editorial Board Member:
Volume: 9 Issue: 2
Author(s): Alfredo Ulloa-Aguirre
Affiliation:
Export Options
About this article
Cite this article as:
Ulloa-Aguirre Alfredo, Meet Our Editorial Board Member:, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2015; 9 (2) . https://dx.doi.org/10.2174/187221480902151221152836
DOI https://dx.doi.org/10.2174/187221480902151221152836 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
19
Related Articles
-
Role of Cellular Elements in Thrombus Formation and Dissolution
Cardiovascular & Hematological Agents in Medicinal Chemistry Enhancement of the Pharmacological Efficacy of FGF-21 by Genetic Modification and PEGylation
Current Pharmaceutical Biotechnology Nutritional and Therapeutic Potential of Spirulina
Current Pharmaceutical Biotechnology Plant-Derived Biomolecules and Drug Delivery Systems in the Treatment of Liver and Kidney Diseases
Current Pharmaceutical Design DNA Methylation, An Epigenetic Mode of Gene Expression Regulation in Reproductive Science
Current Pharmaceutical Design Pharmacogenetics of Asthma Therapy
Current Pharmaceutical Design Malignant Hypertension: A Rare Problem or is it Underdiagnosed?
Current Vascular Pharmacology An Update on Animal Models of Autoimmune Hepatitis: Are we There Yet?
Current Pharmaceutical Design Bioinformatics Analysis of Functional Protein Sequences Reveals a Role for Tumor Necrosis Factor-α and Nitric Oxide in Insulin Resistance Syndrome
Current Nutrition & Food Science Biological Markers in Older People at Risk of Mobility Limitations
Current Pharmaceutical Design Pregabalin in Neuropathic Pain: Evidences and Possible Mechanisms
Current Neuropharmacology NPY and Cardiac Diseases
Current Topics in Medicinal Chemistry Design, Synthesis and Biological Evaluation of Spiro Cyclohexane-1,2- Quinazoline Derivatives as Potent Dipeptidyl Peptidase IV Inhibitors
Mini-Reviews in Medicinal Chemistry Hypothalamic Leptin and Ghrelin Signaling as Targets for Improvement in Metabolic Control
Current Pharmaceutical Design Aldose Reductase in the Retina
Current Enzyme Inhibition Role of Endogenous Androgen Against Insulin Resistance and Athero-sclerosis in Men with Type 2 Diabetes
Current Diabetes Reviews Gold Nanoparticle Based Systems in Genetics
Current Pharmacogenomics Oxidative Stress and Antioxidants in Carcinogenesis and Integrative Therapy of Cancer
Current Pharmaceutical Design Impact of Oral 1,25-Dihydroxy Vitamin D (Calcitriol) Replacement Therapy on Coronary Artery Risk Factors in Type 2 Diabetic Patients
Endocrine, Metabolic & Immune Disorders - Drug Targets Immunoglobulin Free Light Chains in Immune Responses
Current Immunology Reviews (Discontinued)